future of bcma-targeting car-t for myeloma
Published 3 years ago • 227 plays • Length 6:00Download video MP4
Download video MP3
Similar videos
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
3:35
the future of anti-bcma car t-cell therapy in myeloma
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
2:14
future role of car-t in myeloma
-
1:31
integrating bcma-directed bispecifics and car-t into the myeloma treatment landscape
-
4:51
promising bcma-targeting car-t cells for relapsed myeloma
-
1:29
sequencing bcma-targeted therapies in myeloma
-
1:34
bcma-targeting car-t: lessons moving forward
-
1:45
targetting bcma in myeloma
-
1:13
the future of car t-cells and bispecific antibodies to treat myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:45
anti-bcma car t-cell therapy for multiple myeloma: latest studies
-
1:13
car t-cells: targeting bcma
-
1:59
investigating the mechanisms of initial & acquired resistance to bcma car-t therapy in myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma